CV Sciences, Inc. Announces its Title Sponsorship of the 24th Annual Hemp Industries Association 2017 National Conference

Aug 9, 2017

CV Sciences, Inc. Cites Research Suggesting Possible Therapeutic Role for Cannabidiol in Alzheimer's and Parkinson's Diseases

Aug 1, 2017

CV Sciences, Inc. Hosts Lunch Seminar at National University of Natural Medicine 2017 Medical Cannabis Conference

Jul 25, 2017

CV Sciences, Inc. Cites Recent Clinical Study on Pharmaceutical-Grade CBD Shown to Lower Blood Pressure

Jul 20, 2017

CV Sciences, Inc. to Exhibit and Present at the Mid-American Health Organization Expo and Summer Splash 2017 Convention

Jul 18, 2017

CV Sciences, Inc. Appoints Dr. Amy M. McCord as Director of Drug Development

Jul 11, 2017

CV Sciences, Inc. Reports Growing Clinical Evidence for Therapeutic Value of Pharmaceutical-Grade Cannabidiol (CBD)

Jul 5, 2017

CV Sciences, Inc. to Exhibit and Present at the American Association of Naturopathic Physicians 2017 National Conference

Jun 27, 2017

CV Sciences, Inc.'s CEO Releases Letter to Stockholders and Customers Regarding Complaint filed by Securities and Exchange Commission

Jun 19, 2017

CV Sciences, Inc. Announces Commencement of IND preparation immediately following Pre-IND Meeting With FDA

Jun 19, 2017